Syros Pharmaceuticals Inc... (SYRS)
0.08
-0.06 (-44.13%)
At close: Mar 03, 2025, 3:59 PM
0.08
-3.43%
Pre-market: Mar 04, 2025, 07:52 AM EST
Syros Pharmaceuticals Ratios Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| PE Ratio | -1.34 | -0.92 | -2.25 | -5.82 | -3.68 | -2.92 | -4.58 | -3.23 | -1.51 | -3.35 | -2.15 |
| PEG Ratio | -0.03 | 0.01 | 0.10 | 9.10 | 2.27 | 0.28 | 0.11 | 0.05 | -0.01 | 0.09 | n/a |
| PS Ratio | 22.21 | 3.05 | 8.68 | 33.11 | 140.23 | 88.73 | 224.53 | 487.03 | 141.74 | n/a | n/a |
| PB Ratio | 13.24 | 0.36 | 2.39 | 5.52 | 3.51 | 2.31 | 3.78 | 1.92 | 1.32 | 0.75 | 5.01 |
| P/FCF Ratio | -2.01 | -0.36 | -2.02 | -8.23 | -3.81 | -4.36 | -5.43 | -3.6 | -1.86 | -3.69 | -2.46 |
| P/OCF Ratio | -2.01 | -0.37 | -2.05 | -8.71 | -4.61 | -4.51 | -5.53 | -3.81 | -1.95 | -3.75 | -2.77 |
| OCF/S Ratio | -11.04 | -8.27 | -4.24 | -3.8 | -30.4 | -19.67 | -40.63 | -127.87 | -72.65 | n/a | n/a |
| Debt / Equity Ratio | 3.73 | 0.50 | 0.76 | 0.73 | 0.33 | 0.00 | 0.00 | 0.00 | 0.01 | n/a | n/a |
| Quick Ratio | 3.95 | 6.87 | 4.33 | 6.24 | 4.86 | 5.21 | 5.89 | 8.94 | 4.58 | 48.36 | 4.30 |
| Current Ratio | 3.95 | 6.87 | 4.33 | 6.24 | 4.87 | 5.21 | 5.89 | 8.94 | 4.58 | 48.36 | 4.30 |
| Asset Turnover | 0.06 | 0.06 | 0.13 | 0.07 | 0.01 | 0.02 | 0.01 | 0.00 | 0.01 | n/a | n/a |
| Interest Coverage | -25.16 | -32.87 | -25.45 | -45.92 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -9.88 | -0.39 | -1.06 | -0.95 | -0.95 | -0.79 | -0.83 | -0.59 | -0.88 | -0.22 | -2.33 |
| Return on Assets (ROA) | -0.98 | -0.2 | -0.49 | -0.4 | -0.5 | -0.58 | -0.69 | -0.52 | -0.68 | -0.22 | -1.88 |
| Return on Capital (ROIC) | -0.98 | -0.64 | -0.66 | -0.45 | -0.61 | -0.74 | -0.83 | -0.59 | -0.84 | -0.22 | -2.15 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 77.33% | 80.06% | 100.00% | 100.00% | 100.00% | 100.00% | -38.69% | 100.00% | -89.91% | n/a | n/a |
| Net Profit Margin | -1.66K% | -331.32% | -385.15% | -568.67% | -3.81K% | -3.04K% | -4.91K% | -15.06K% | -9.41K% | n/a | n/a |
| Pretax Profit Margin | -1.66K% | -636.12% | -368.52% | -556.8% | -3.81K% | -3.04K% | -4.91K% | -15.06K% | -9.41K% | n/a | n/a |
| Operating Profit Margin | -1.3K% | -913.12% | -423.28% | -545.27% | -3.92K% | -3.14K% | -4.97K% | -15.13K% | -9.41K% | n/a | n/a |
| FCF Margin | -1.11K% | -835.39% | -429.09% | -402.17% | -3.68K% | -2.03K% | -4.14K% | -13.52K% | -7.64K% | n/a | n/a |
| EBITDA Margin | -1.58K% | -588.39% | -339.04% | -524.82% | -3.67K% | -2.96K% | -4.83K% | -14.73K% | -9.22K% | n/a | n/a |